07 June 2020
Visiongain has launched a new pharma report Dental Bone Graft Substitutes Market Report 2020-2030: Forecasts by Type (Allograft, Demineralized Allograft, Synthetic Bone Graft, Xenograft), Application (Implant Bone Regeneration, Periodontal Defect Regeneration, Ridge Augmentation, Sinus Lift, Socket Preservation), Product (Bio OSS, Grafton, Osteograf), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).
The global dental bone graft substitutes market is anticipated to grow at a lucrative CAGR of xyz% and anticipated to reach USD xyz million by 2020 owing to rising dental implant surgeries, growing inclination towards cosmetic dentistry, and rising industry standards. However, unfavorable reimbursement scenarios in some countries are anticipated to challenge market growth over the forecast period.
The dental bone graft is used to replace and promote bone development that has arisen in the dental bone. They serve as a mineral reserve that allows new bone development. When the new bone is created, it removes the graft that has been filled in. Bone deformity induced by cancer, damage, or resorption shall be treated by grafting. Numerous technical developments in the dental graft are taking place globally owing to massive investments by the government and major players in the oral health market. It may be in the shape of injectable, putty, and granules.
The growing dental tourism across the Asia Pacific region is fueling the market growth. In particular China, India, and Thailand, are a major regional contributor to this development. Low-cost dental care procedures and the availability of qualified surgeons are anticipated to augur market growth of the Asia Pacific region over the forecast period from 2020 to 2030.
Furthermore, the growing target population is boosting global dental bone graft substitutes market growth. According to the Department of Economic and Social Affairs Population Division, the global proportion of citizens aged 60 is projected to grow to 21.1% by 2050. Elevated incidence of periodontal diseases, root caries and edentulous diseases in the geriatric community is anticipated to fuel market growth for bone grafts and substitutes
North America holds the majority of market share followed by Europe and will continue to dominate in the future as a result of several research projects in the region, coupled with funding for research institutes from the government. Also, the market will continue to be driven by the existence of the target population and increased R&D investment by important business organizations. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to growing medical tourism and government initiatives across the region. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the dental bone graft substitutes market growth over the forecast period.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global dental bone graft substitutes market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the dental bone graft substitutes market.
For instance, in February 2019; Medtronic had launched Grafton Demineralized Bone Matrix (DBM) for the spine and orthopedic procedures. It was launched in Japan and was granted PMDA approval. The product is bone graft extender, bone void filler, and bone graft substitute. This launch has extended the product portfolio of the company and has increased its number of customers.
The comprehensive market report features companies such as ACE Surgical Supply,Inc., AlloSource, Baxter, Biobank, Biohorizons Iph, Inc., Dentium, Dentsply Sirona International, Geistlich Pharma AG, Institut Straumann AG, Lifenet Health, Medtronic, Nuvasive, Inc., Orthofix Holdings, Inc., OST Développement, RTI Surgical, Inc., Smith & Nephew, Inc., Stryker Corporation, TBF Tissue Engineering, Wright Medical Group N.V., Zimmer Holding Inc among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.
29 September 2022
The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.
21 September 2022
The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.
16 September 2022
The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.